Rina Plattner

2006

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Rina Plattner trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. P. Thiery (in Cell Biology)

Papers from Rina Plattner's perspective

Ordered by how strongly the researchers Rina Plattner trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Epithelial–mesenchymal transitions in tumour progression (Nature Reviews. Cancer)
  2. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. (New England Journal of Medicine)
  3. ErbB receptors: directing key signaling networks throughout life. (Annual Review of Pharmacology and Toxicology)
  4. Structural basis for the autoinhibition of c-Abl tyrosine kinase. (Cell)
  5. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered… (Journal of Clinical Oncology)
  6. Contact Inhibition of Locomotion in vivo controls neural crest directional migration (Nature)
  7. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression (EMBO Molecular Medicine)
  8. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab (Nature)
  9. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. (Molecules and Cells)
  10. The ErbB signaling network: receptor heterodimerization in development and cancer (EMBO Journal)

Their papers